Lan Yu (兰宇)兰宇
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 蓬莱诺康药业有限公司Chinese legal name: 蓬莱诺康药业有限公司
主要成分Active Ingredients
- 新鱼腥草素钠Xinyu Xingcao Suna
药物知识说明
新鱼腥草素钠是一种在国家药监局注册认定的药品。该药品含有新鱼腥草素钠-64eec826等成分。
该药品关联的活性成分包括：新鱼腥草素钠Xinyu Xingcao Suna。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：蓬莱诺康药业有限公司Chinese legal name: 蓬莱诺康药业有限公司。
您可以探索含有相同成分的其他药品：新鱼腥草素钠-64eec826成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 兰宇) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 新鱼腥草素钠Xinyu Xingcao Suna.
Manufacturers recorded for this product: 蓬莱诺康药业有限公司Chinese legal name: 蓬莱诺康药业有限公司.
Explore other medicines containing the same ingredient: 新鱼腥草素钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 兰宇Recorded Chinese name: 兰宇
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 8mg8 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 蓬莱诺康药业有限公司Chinese legal name: 蓬莱诺康药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20051336
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20051336
Manufacturer
Chinese legal name: 蓬莱诺康药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20051336
生产企业
蓬莱诺康药业有限公司(国产)
适应症
1.适用于附件炎、盆腔炎、慢性宫颈炎等妇科各类炎症。|2.并用于上呼吸道感染，慢性支气管炎、肺炎等。
用法用量
1.肌肉注射：一次8mg，一日2次(5%～10%葡萄糖注射液配制成2mg/ml后肌肉注射)。|2.静脉滴注：一次16～20mg，用5%～10%葡萄糖注射液250～500ml溶解稀释后缓慢滴注。
不良反应
有关本品不良反应的报道较少，临床应用观察到的不良反应主要有过敏反应，如皮疹、注射后头晕等。
禁忌
对本品中任何成份过敏者禁用。
注意事项
1.使用过程中应密切观察可能的过敏反应。|2.使用本品期间，如出现任何不良事件和不良反应，请咨询医生。|3.同时使用其他药品，请告知医生。|4.请放置于儿童不能够触及的地方。
贮藏
遮光，密闭保存。
规格
8mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.